LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

Search

Omnicell Inc

Fechado

SetorSaúde

43.86 1.5

Visão Geral

Variação de preço das ações

24h

Atual

Mín

43.44

Máximo

43.88

Indicadores-chave

By Trading Economics

Rendimento

-177K

5.5M

Vendas

20M

311M

P/E

Médio do Setor

101.279

77.671

EPS

0.51

Margem de lucro

1.758

Funcionários

3,600

EBITDA

524K

31M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+5.63% upside

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

598M

2B

Abertura anterior

42.36

Fecho anterior

43.86

Sentimento de Notícias

By Acuity

50%

50%

153 / 374 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bearish Evidence

Omnicell Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

13 de dez. de 2025, 00:04 UTC

Aquisições, Fusões, Aquisições de Empresas

Intel in Talks to Acquire SambaNova in Deal Valued at $1.6 Billion, Bloomberg Reports, Citing Sources

12 de dez. de 2025, 16:42 UTC

Aquisições, Fusões, Aquisições de Empresas

FTC Sues to Block Henkel's $725 Million Deal for Liquid Nails From PE Firm -- 2nd Update

13 de dez. de 2025, 16:48 UTC

Aquisições, Fusões, Aquisições de Empresas

How the War to Win Warner Bros. Discovery Will Be Won -- Barrons.com

13 de dez. de 2025, 08:00 UTC

Aquisições, Fusões, Aquisições de Empresas

How the War to Win Warner Bros. Discovery Will Be Won -- Barrons.com

13 de dez. de 2025, 07:00 UTC

Aquisições, Fusões, Aquisições de Empresas

A Chubb/AIG Deal Could Be Good for Shareholders and a Coup for Greenberg Family -- Barrons.com

13 de dez. de 2025, 00:24 UTC

Aquisições, Fusões, Aquisições de Empresas

Want a Piece Of SpaceX? -- Barrons.com

12 de dez. de 2025, 23:49 UTC

Aquisições, Fusões, Aquisições de Empresas

Intel in Talks to Acquire SambaNova in Deal Valued at $1.6B, Bloomberg Reports, Citing Sources

12 de dez. de 2025, 22:52 UTC

Conversa de Mercado

Nike Expected to Show Further Momentum in 2Q Results -- Market Talk

12 de dez. de 2025, 22:32 UTC

Ganhos

These Stocks Moved the Most Today: Broadcom, Oracle, Fermi, Tilray, Lululemon, Costco, Netskope, and More -- Barrons.com

12 de dez. de 2025, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

12 de dez. de 2025, 20:45 UTC

Ganhos

The Best Dividend ETF for Right Now -- and 2026 -- Barrons.com

12 de dez. de 2025, 20:41 UTC

Conversa de Mercado

Oil Ends Week Lower As Market Frets About Oversupply -- Market Talk

12 de dez. de 2025, 20:20 UTC

Conversa de Mercado

U.S. Natural Gas Futures Post Hefty Weekly Loss -- Market Talk

12 de dez. de 2025, 19:23 UTC

Ganhos

Charles Schwab Is Opening New Accounts and Hauling in New Assets Amid Buoyant Stock Market -- Barrons.com

12 de dez. de 2025, 18:35 UTC

Aquisições, Fusões, Aquisições de Empresas

PNC Financial Expects to Close FirstBank Deal On or About Jan. 5, Subject to Satisfaction of Customary Closing Conditions

12 de dez. de 2025, 18:33 UTC

Aquisições, Fusões, Aquisições de Empresas

PNC Receives Regulatory Approvals For Acquisition Of FirstBank >PNC

12 de dez. de 2025, 18:31 UTC

Conversa de Mercado

U.S. Oil Rig Count Edges Up by 1 to 414 -- Market Talk

12 de dez. de 2025, 17:49 UTC

Ganhos

Tariffs Mean Costco Has Fewer Product Types This Holiday. But It Has Plenty of Pies. -- WSJ

12 de dez. de 2025, 17:34 UTC

Aquisições, Fusões, Aquisições de Empresas

Orange: Closing Subject to Customary Regulatory Approvals, Other Closing Conditions

12 de dez. de 2025, 17:33 UTC

Aquisições, Fusões, Aquisições de Empresas

Orange: Closing of the Transaction Is Expected in the First Half of 2026

12 de dez. de 2025, 17:33 UTC

Aquisições, Fusões, Aquisições de Empresas

Orange: Agreement Confirms the Non-Binding Agreement That Was Previously Announced Oct. 31

12 de dez. de 2025, 17:32 UTC

Aquisições, Fusões, Aquisições de Empresas

Orange: MasOrange Is Spain's Leading Operator in Terms of Customer Base

12 de dez. de 2025, 17:31 UTC

Aquisições, Fusões, Aquisições de Empresas

Orange to Buy the Stake for EU4.25B in Cash

12 de dez. de 2025, 17:24 UTC

Conversa de Mercado

Argentina Predicts Record Wheat Crop -- Market Talk

12 de dez. de 2025, 17:20 UTC

Conversa de Mercado
Ganhos

Tech, Media & Telecom Roundup: Market Talk

12 de dez. de 2025, 17:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

12 de dez. de 2025, 17:18 UTC

Conversa de Mercado
Ganhos

Broadcom, Oracle Investor Reactions Show High Bar for AI Cos. -- Market Talk

12 de dez. de 2025, 17:09 UTC

Conversa de Mercado

Broadcom Investors Were Primed to Sell Shares -- Market Talk

12 de dez. de 2025, 17:09 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

12 de dez. de 2025, 16:47 UTC

Conversa de Mercado

Broadcom's Margins Expected to Narrow Due to AI Revenue -- Market Talk

Comparação entre Pares

Variação de preço

Omnicell Inc Previsão

Preço-alvo

By TipRanks

5.63% parte superior

Previsão para 12 meses

Média 46.33 USD  5.63%

Máximo 50 USD

Mínimo 43 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para Omnicell Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

4 ratings

3

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

24.23 / 30.44Suporte e Resistência

Curto Prazo

Strong Bearish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

153 / 374 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat